Discussion
Using a short course of low-dose methotrexate, an immunosuppressive agent, alongside enzyme replacement therapy (ERT) in people with Pompe disease may help prevent the formation of antibodies that can reduce treatment effectiveness. That’s the key finding of a new study by Duke University researchers, who found that…